February 2020 – Pharmacy Times CE: The Rapidly Evolving Treatment Landscape for Hepatocellular Carcinoma (HCC)


Courtney C. Cavalieri, PharmD, BCOP
Clinical Oncology Pharmacist
Gastrointestinal and Thoracic Oncology
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah


Tuesday, February 18th, 2020 at 6:00 PM


Heritage Club at Bethpage
99 Quaker Meeting House Road
Farmingdale, NY 11735

Educational Objectives:

  • Identify characteristics, including risk factors, that would suggest a patient should be referred for potential evaluation for hepatocellular carcinoma (HCC)
  • Describe the current drug classes that are used in the treatment of patients with advanced HCC and their placement in guidelines
  • Explain what therapies are currently bring studied for the treatment of advanced HCC and their potential places in therapy
  • Develop monitoring plans for patients undergoing treatment for advanced HCC, including management of dosing recommendations, drug interactions, and adverse effects

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s